Abstract | BACKGROUND: DESIGN AND METHODS: RESULTS: After adjustment for other cardiovascular risk factors, A1 and A3 haplotypes protected against premature myocardial infarction (odds ratio 0.7, 95% CI 0.4-0.8, p=0.044 and 0.5, 0.3-0.6, p<0.001, respectively). Moreover, the protective role of these haplotypes seemed to be additive, as carriers of both the A1 and A3 haplotypes had adjusted odds ratios of 0.3 (0.2-0.5, p<0.001) and 0.4 (0.2-0.8, p=0.006) compared to those carrying only the A1 or A3 haplotype, respectively. The presence of the A1 haplotype was associated with increased levels of activated protein C whereas individuals carrying the A3 haplotype showed the highest soluble endothelial protein C receptor levels. CONCLUSIONS: These results show that A1 haplotype carriers have a reduced risk of premature myocardial infarction via the association of this haplotype with increased activated protein C plasma levels. The study also shows that carriers of the A3 haplotype have a reduced risk of myocardial infarction, only in part due to increased soluble endothelial protein C levels.
|
Authors | Pilar Medina, Silvia Navarro, Javier Corral, Esther Zorio, Vanessa Roldán, Amparo Estellés, Amparo Santamaría, Francisco Marín, Joaquín Rueda, Rogier M Bertina, Francisco España, RECAVA Thrombosis Groups |
Journal | Haematologica
(Haematologica)
Vol. 93
Issue 9
Pg. 1358-63
(Sep 2008)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 18757851
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD
- Endothelial Protein C Receptor
- PROCR protein, human
- Protein C
- Receptors, Cell Surface
|
Topics |
- Adult
- Alleles
- Antigens, CD
(genetics)
- Endothelial Protein C Receptor
- Enzyme Activation
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(genetics)
- Polymorphism, Genetic
(genetics)
- Protein C
(genetics, metabolism)
- Receptors, Cell Surface
(genetics)
- Risk Factors
|